RAPD analysis of astragalus medicines marketed in Taiwan

Kur Ta Cheng, Borcherng Su, Chien Tsu Chen, Chun Ching Lin

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

The genetic variability of Astragalus medicine materials sold by twenty randomly selected stores in Taiwan was investigated using RAPD analysis in order to obtain available primers which could clearly differentiate among them. Total DNA isolated from the rhizomes of the samples were used as templates, and sixty 10 mer arbitrary primers were used in the analysis. The aim of the present study is to construct an identification model of molecular biotechniques applicable to Chinese herbal medicines in RAPD analysis. Three of the primers, OPT-03, OPT-13, and OPT-17, revealed polymorphic RAPD fingerprints among the samples of Astragalus membranaceiis, and between Astragalus membranaceits and Hcdysammpolybotrys samples. SSCP analysis was also conducted on PCR products from the ITS-1 region of ribosomal DNA in order to differentiate the two species.

Original languageEnglish
Pages (from-to)273-278
Number of pages6
JournalAmerican Journal of Chinese Medicine
Volume28
Issue number2
Publication statusPublished - 2000
Externally publishedYes

Fingerprint

Single-Stranded Conformational Polymorphism
Rhizome
Molecular Models
Herbal Medicine
Dermatoglyphics
Ribosomal DNA
Taiwan
Medicine
Polymerase Chain Reaction
DNA

ASJC Scopus subject areas

  • Complementary and alternative medicine

Cite this

RAPD analysis of astragalus medicines marketed in Taiwan. / Cheng, Kur Ta; Su, Borcherng; Chen, Chien Tsu; Lin, Chun Ching.

In: American Journal of Chinese Medicine, Vol. 28, No. 2, 2000, p. 273-278.

Research output: Contribution to journalArticle

@article{33010de6619c45e58dd1f008c205bdd9,
title = "RAPD analysis of astragalus medicines marketed in Taiwan",
abstract = "The genetic variability of Astragalus medicine materials sold by twenty randomly selected stores in Taiwan was investigated using RAPD analysis in order to obtain available primers which could clearly differentiate among them. Total DNA isolated from the rhizomes of the samples were used as templates, and sixty 10 mer arbitrary primers were used in the analysis. The aim of the present study is to construct an identification model of molecular biotechniques applicable to Chinese herbal medicines in RAPD analysis. Three of the primers, OPT-03, OPT-13, and OPT-17, revealed polymorphic RAPD fingerprints among the samples of Astragalus membranaceiis, and between Astragalus membranaceits and Hcdysammpolybotrys samples. SSCP analysis was also conducted on PCR products from the ITS-1 region of ribosomal DNA in order to differentiate the two species.",
author = "Cheng, {Kur Ta} and Borcherng Su and Chen, {Chien Tsu} and Lin, {Chun Ching}",
year = "2000",
language = "English",
volume = "28",
pages = "273--278",
journal = "American Journal of Chinese Medicine",
issn = "0192-415X",
publisher = "World Scientific Publishing Co. Pte Ltd",
number = "2",

}

TY - JOUR

T1 - RAPD analysis of astragalus medicines marketed in Taiwan

AU - Cheng, Kur Ta

AU - Su, Borcherng

AU - Chen, Chien Tsu

AU - Lin, Chun Ching

PY - 2000

Y1 - 2000

N2 - The genetic variability of Astragalus medicine materials sold by twenty randomly selected stores in Taiwan was investigated using RAPD analysis in order to obtain available primers which could clearly differentiate among them. Total DNA isolated from the rhizomes of the samples were used as templates, and sixty 10 mer arbitrary primers were used in the analysis. The aim of the present study is to construct an identification model of molecular biotechniques applicable to Chinese herbal medicines in RAPD analysis. Three of the primers, OPT-03, OPT-13, and OPT-17, revealed polymorphic RAPD fingerprints among the samples of Astragalus membranaceiis, and between Astragalus membranaceits and Hcdysammpolybotrys samples. SSCP analysis was also conducted on PCR products from the ITS-1 region of ribosomal DNA in order to differentiate the two species.

AB - The genetic variability of Astragalus medicine materials sold by twenty randomly selected stores in Taiwan was investigated using RAPD analysis in order to obtain available primers which could clearly differentiate among them. Total DNA isolated from the rhizomes of the samples were used as templates, and sixty 10 mer arbitrary primers were used in the analysis. The aim of the present study is to construct an identification model of molecular biotechniques applicable to Chinese herbal medicines in RAPD analysis. Three of the primers, OPT-03, OPT-13, and OPT-17, revealed polymorphic RAPD fingerprints among the samples of Astragalus membranaceiis, and between Astragalus membranaceits and Hcdysammpolybotrys samples. SSCP analysis was also conducted on PCR products from the ITS-1 region of ribosomal DNA in order to differentiate the two species.

UR - http://www.scopus.com/inward/record.url?scp=0033654685&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033654685&partnerID=8YFLogxK

M3 - Article

VL - 28

SP - 273

EP - 278

JO - American Journal of Chinese Medicine

JF - American Journal of Chinese Medicine

SN - 0192-415X

IS - 2

ER -